Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Work In Process: 2020-2024

Historic Work In Process for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $10.1 million.

  • Maravai Lifesciences Holdings' Work In Process fell 9.73% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year decrease of 9.73%. This contributed to the annual value of $10.1 million for FY2024, which is 20.74% down from last year.
  • According to the latest figures from FY2024, Maravai Lifesciences Holdings' Work In Process is $10.1 million, which was down 20.74% from $12.7 million recorded in FY2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Work In Process peaked at $21.9 million during FY2022, and registered a low of $10.1 million during FY2024.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Work In Process value was $12.7 million (recorded in 2023), while the average stood at $14.9 million.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Work In Process climbed by 16.63% in 2021 and then plummeted by 42.23% in 2023.
  • Yearly analysis of 5 years shows Maravai Lifesciences Holdings' Work In Process stood at $18.3 million in 2020, then increased by 16.63% to $21.4 million in 2021, then increased by 2.66% to $21.9 million in 2022, then tumbled by 42.23% to $12.7 million in 2023, then decreased by 20.74% to $10.1 million in 2024.